Skull Base Rep 2011; 1(2): 129-132
DOI: 10.1055/s-0031-1284208
© Thieme Medical Publishers

Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report

Enrico Maria Trecarichi1 , Jacopo Galli2 , Enrica Tamburrini1 , Katleen de Gaetano Donati1 , Giancarlo Scoppettuolo1 , Cesare Colosimo3 , Francesco Pierconti4 , Gaetano Paludetti2 , Mario Tumbarello1
  • 1Institutes of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
  • 2Otolaryngology, Catholic University of the Sacred Heart, Rome, Italy
  • 3Bio-images, and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
  • 4Pathological Anatomy, Catholic University of the Sacred Heart, Rome, Italy
Further Information

Publication History

Publication Date:
22 July 2011 (eFirst)

ABSTRACT

Esthesioneuroblastoma (ENB) is an uncommon malignant tumor derived from the specialized neuroepithelium of the upper nasal cavity. The largest case series and meta-analyses suggest the combination of surgery and radiotherapy as the gold standard treatment for ENB. However, an increasing number of case series have reported excellent survival and few complications with minimally invasive endoscopic resection (MIER) in conjunction with radiotherapy of EBN in early stages of the disease. In this case report, the authors describe the first case of ENB in a young adult man who was human immunodeficiency virus (HIV)-1 and Hepatitis C virus (HCV) coinfected. The authors discuss all the aspects of this rare disease, focusing on treatment options and prognosis.